Amundi Has $307.42 Million Position in Mettler-Toledo International, Inc. $MTD

Amundi lifted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 40.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 240,640 shares of the medical instruments supplier's stock after purchasing an additional 69,620 shares during the quarter. Amundi owned about 1.20% of Mettler-Toledo International worth $307,420,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Whipplewood Advisors LLC bought a new stake in Mettler-Toledo International in the 1st quarter valued at $25,000. Reflection Asset Management bought a new position in Mettler-Toledo International during the 4th quarter worth about $26,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at about $26,000. Elyxium Wealth LLC acquired a new stake in shares of Mettler-Toledo International in the 4th quarter valued at about $29,000. Finally, Transamerica Financial Advisors LLC bought a new stake in shares of Mettler-Toledo International in the second quarter valued at about $32,000. 95.07% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Thomas Salice sold 417 shares of the company's stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total value of $600,650.97. Following the sale, the director directly owned 292 shares of the company's stock, valued at approximately $420,599.72. This represents a 58.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 2,240 shares of the firm's stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the completion of the sale, the chief financial officer owned 5,579 shares of the company's stock, valued at $7,989,128. This trade represents a 28.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,254 shares of company stock valued at $6,092,712 over the last quarter. 0.71% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Down 0.0%

Shares of Mettler-Toledo International stock opened at $1,344.87 on Tuesday. The stock has a market cap of $26.95 billion, a P/E ratio of 30.27, a P/E/G ratio of 2.70 and a beta of 1.22. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45. Mettler-Toledo International, Inc. has a 12-month low of $1,023.05 and a 12-month high of $1,525.17. The business's 50 day moving average is $1,363.35 and its 200-day moving average is $1,274.05.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping analysts' consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the company earned $10.09 earnings per share. The firm's revenue for the quarter was up 4.5% on a year-over-year basis. Equities research analysts predict that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Weiss Ratings upgraded Mettler-Toledo International from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, August 4th. Robert W. Baird cut their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a "neutral" rating on the stock in a research note on Monday, May 11th. Rothschild & Co Redburn started coverage on Mettler-Toledo International in a research report on Wednesday, September 2nd. They set a "sell" rating and a $1,200.00 price target for the company. Jefferies Financial Group raised their price target on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. cut their price objective on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a "neutral" rating on the stock in a research report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $1,445.31.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.